Sukhmani K. Padda, MD, thoracic medical oncologist, https://bio.cedars-sinai.org/paddas/index.html, was the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, September 2, 2021. Dr. Padda was recently named Director of Thoracic Medical Oncology at Cedars-Sinai Cancer in Los Angeles, California. In collaboration with multidisciplinary clinical experts and scientists, Dr. Padda’s work focuses on expanding clinical trials and translational research in thoracic oncology. The ultimate goal of this research is to improve the outcomes of patients with thoracic malignancies.

Dr. Padda has a particular interest in improving treatment for patients with rare thoracic tumors — such as thymic malignancies and lung neuroendocrine tumors — and genomic subsets of lung cancer, such as KRAS- and EGFR-positive tumors. Dr. Padda also conducts research into tumor biomarkers to help determine optimal treatments for patients.
She works with thoracic oncology experts around the country, leading and participating in clinical trials through the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) Cooperative Groups (e.g., ECOG, SWOG). She chairs the International Association for the Study of Lung Cancer (IASLC) Career Development/Fellowship Committee, which provides funding to early career lung cancer researchers around the world. Dr. Padda is a member of the North American Neuroendocrine Tumor Society (NANETS) and International Thymic Malignancy Interest Group (ITMIG). She has authored and co-authored dozens of papers and articles for peer-reviewed publications and is a peer reviewer for a number of prestigious cancer journals, including the Journal of Clinical Oncology and JAMA Oncology.

CCF’s Luncheon with the Experts series features physicians and healthcare professionals, support group leaders, patients, and colleagues who are key opinion leaders in the neuroendocrine cancer community worldwide.

This weekly series is presented via Facebook Live on Thursdays from 12 noon to 1 pm, Eastern Time. Join us for unique discussions on a wide variety of topics for everyone in the NET community!

With special thanks to TerSera Therapeutics, sponsor of the Luncheon with the Experts series.

Do you want to receive notifications every time CCF uploads a new video on YouTube? Be sure to CLICK LIKE, SUBSCRIBE, and HIT THE BELL.

Cancer Research And Statistic Foundation organized a webinar "Lung cancer congress Rare Malignancies 2023" with the support of "Institute of Pulmonology Medical Research & Development" & "Sunrise Oncology Centre".

Date: 02 March 2023 (Day - 1)
Time: 07:00 pm to 09:10 pm

Follow us:

CRSF Online: https://crsf.in/

Facebook: https://bit.ly/3QfMTrX

Twitter: https://bit.ly/3vBQAR7

LinkedIn: https://bit.ly/3zVG7m8

Event Managed By:
Horizon Conference Management

#crsf #LungCongress #LungCancer #cancer #cancertreatment #cancerawareness #oncologists #cancerresearch

Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Did you know that about 1 in 4 NETs develop in the lungs?
Lung NETs are often overlooked, less frequently discussed, and more misunderstood than NETs that begin in the pancreas or GI tract. It can be frustrating for individuals and families living with a lung NET to find useful information or the right health care professional to work with. This special episode of NETRF's NETWise covers all things Lung NETs.

Do you want to learn more about the classification of the different types of lung NETs? In this episode, we map out the lung NET classification system. While we mainly focus on typical and atypical carcinoids, we also included information about large cell and small cell lung cancer. We talk about each different type of lung NET, their distinctive characteristics, and what they have in common. We did not forget about DIPNECH. Information about this ultra-rare condition is also included in this episode.

This episode is for every person and family affected by lung NETs. We hear your call for more information. After you listen to this episode, you will have a better understanding of the classification system of lung NETs, surgical options (including the controversial ones), medical treatments, and how you can get involved with research to advocate for more approved treatment options.

MENTIONED IN THIS EPISODE:
Share Your Story - https://netrf.org/for-patients/patient-stories/
Lung NETs - https://netrf.org/for-patients..../nets-info/tumor-sit
A Look at Lung NETs - https://netrf.org/2019/11/18/l....earn-about-lung-nets
VIDEO: Medical Management of Lung NETs – Dr. Ed Wolin, Mount Sinai Medical Center https://youtu.be/lXZwCS1U8SE
VIDEO: Basics of Lung NET Diagnosis and Treatment – Dr. Sukhmani Padda – Stanford University
https://youtu.be/qAKNkPj800o
VIDEO: Surgical Treatment of Lung NETs – Dr. Andrew Kaufman – Mount Sinai
https://youtu.be/2zGKjOkCiT4

ADDITIONAL NET RESEARCH FOUNDATION RESOURCES:
Request a Mailed Copy of our Neuroendocrine Cancer Guide
https://netrf.org/for-patients/guide/

Information and Resources for the Newly Diagnosed
https://netrf.org/for-patients/newly-diagnosed/

This episode was made possible by the generous support of Ipsen Biopharmaceuticals, the Vincent E. Taylor Patient Education Fund, Advanced Accelerator Applications, a Novartis Company, and Lexicon Pharmaceuticals.